These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7735740)

  • 1. Magnetic resonance imaging in myelodysplastic syndromes.
    Lewis S; Wainscoat JS; Moore NR; Golding SJ
    Br J Radiol; 1995 Feb; 68(806):121-7. PubMed ID: 7735740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of magnetic resonance imaging of femoral marrow in patients with myelodysplastic syndromes.
    Takagi S; Tanaka O; Origasa H; Miura Y
    J Clin Oncol; 1999 Jan; 17(1):277-83. PubMed ID: 10458243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of bone marrow colony growth in the myelodysplastic syndromes with the FAB classification and the Bournemouth score.
    Oscier DG; Worsley A; Darlow S; Figes A; Williams JD; Hamblin TJ
    Leuk Res; 1989; 13(9):833-9. PubMed ID: 2796388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome analyses in patients with myelodysplastic syndromes: correlation with bone marrow histopathology and prognostic significance.
    Werner M; Maschek H; Kaloutsi V; Choritz H; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(1):47-52. PubMed ID: 1636249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD34/QBEND10 immunostaining in bone marrow biopsies: an additional parameter for the diagnosis and classification of myelodysplastic syndromes.
    Baur AS; Meugé-Moraw C; Schmidt PM; Parlier V; Jotterand M; Delacrétaz F
    Eur J Haematol; 2000 Feb; 64(2):71-9. PubMed ID: 10997326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are 'dysplastic' and hypogranular megakaryocytes specific markers for myelodysplastic syndrome?
    Wong KF; Chan JK
    Br J Haematol; 1991 Apr; 77(4):509-14. PubMed ID: 2025576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Magnetic resonance imaging of the bone marrow in patients with aplastic anemia and myelodysplastic syndrome].
    Kusumoto S
    Rinsho Ketsueki; 1992 Apr; 33(4):423-9. PubMed ID: 1602604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual specific cutaneous lesions in myelodysplastic syndromes.
    Aractingi S; Bachmeyer C; Miclea JM; Vérola O; Rousselot P; Dubertret L; Daniel MT
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):187-91. PubMed ID: 7622643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.
    Lorand-Metze I; Pinheiro MP; Ribeiro E; de Paula EV; Metze K
    Leuk Res; 2004 Jun; 28(6):587-94. PubMed ID: 15120935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of the myelodysplastic syndromes (MDS) with special reference to refractory anemia with excess of blasts (RAEB).
    Omine M; Yamauchi H
    Nihon Ketsueki Gakkai Zasshi; 1989 Jul; 52(4):800-10. PubMed ID: 2618556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The myelodysplastic syndromes. Part I. What are they? Part II. Classification.
    Galton DA
    Scand J Haematol Suppl; 1986; 45():11-20. PubMed ID: 3515515
    [No Abstract]   [Full Text] [Related]  

  • 13. Refractory anemia with ringed sideroblasts and chronic myelomonocytic leukemia: myelodysplastic/myeloproliferative disease.
    D'Angelo G
    Lab Hematol; 2005; 11(3):171-3. PubMed ID: 16174602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed myelodysplastic and myeloproliferative syndromes.
    Neuwirtová R; Mociková K; Musilová J; Jelínek J; Havlícek F; Michalová K; Adamkov M
    Leuk Res; 1996 Sep; 20(9):717-26. PubMed ID: 8947580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of the myelodysplastic syndromes.
    Bennett JM
    Clin Haematol; 1986 Nov; 15(4):909-23. PubMed ID: 3471370
    [No Abstract]   [Full Text] [Related]  

  • 16. [Angiogenesis in bone marrow of myelodysplastic syndrome patients].
    Madry K; Dwilewicz-Trojaczek J; Suleiman W; Paszkowska-Kowalewska M; Ziarkiewicz-Wróblewska B
    Pol Arch Med Wewn; 2007 Apr; 117(4):25-30. PubMed ID: 17722472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A specific cutaneous lesion revealing myelodysplastic syndrome.
    Kajisawa C; Matsui C; Morohashi M
    Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [MR imaging findings of the femoral marrow in myelodysplastic syndrome].
    Tanaka O; Takagi S; Matsuura K; Ichikawa T; Kobayashi Y; Nagai J
    Nihon Igaku Hoshasen Gakkai Zasshi; 1995 Oct; 55(12):837-44. PubMed ID: 8539101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trilineage extramedullary myeloid cell tumor in myelodysplastic syndrome.
    Hancock JC; Prchal JT; Bennett JM; Listinsky CM
    Arch Pathol Lab Med; 1997 May; 121(5):520-3. PubMed ID: 9167610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin (rHuEPO) for treatment of myelodysplastic syndrome.
    Zeigler ZR; Jones D; Rosenfeld CS; Shadduck RK
    Stem Cells; 1993 Jan; 11(1):49-55. PubMed ID: 8457781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.